GBCS · Selectis Health, Inc.
$5.73
-0.02 (-0.35%)
At close · Oct 1
Return incl. dividend (before tax)
Going-concern doubt
— cleared Aug 24, 2026
The latest filing states the doubt was alleviated.
“As a result of the Company’s historical losses and projected cash needs, substantial doubt exists about the Company’s ability to continue as a going concern. The Company’s ability to continue as a going concern is contingent upon successful execution of management’s plan over the next twelve months to improve the Company’s liquidity and profitability, which includes, without limitation: Increasing revenue by increasing occupancy in the facilities and increasing Medicaid reimbursement rates; Sale of certain facilities; Controlling operating expenses; and Seeking additional capital through the issuance of debt or equity securities, or the sale of assets. The focus on opportunities within the Company’s current portfolio and future properties to acquire and operate, the settlement, refinance, and continued service of debt obligations, the potential funds generated from stock sales and other initiatives contributing to additional working capital should alleviate any substantial doubt about the Company’s ability to continue as a going concern. However, the Company cannot predict, with certainty, the outcome of these actions to generate liquidity and the failure to do so could negatively impact the Company’s future operations.”View the 10-Q filed Aug 24, 2026
Market Cap
$17.57M
Shares
3.07M
Volume · Oct 1
1400
Avg daily vol (3M)
2509
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$5.73
Open$5.74
Day$5.73–5.74
52W close$1.50–5.83
Avg vol 30d2K
Short int1K · 0.0% float · 1.0d
Short vol3%
Last earningsMay 26, 2021
DataJan 2020–Oct 2026
Filing10-Q · Aug 24
Up next
filed Aug 24, 2026
Metrics snapshot
Useful current figures from the complete screener profile.
Revenue (TTM)
$32.53M
Trailing 12 months
Net income (TTM)
$14.60M
Trailing 12 months
Revenue growth YoY
-54.7%
Year over year
Operating margin
-12.5%
Trailing 12 months
P / E (TTM)
1.4
Trailing earnings · reciprocal yield 73.8%
FCF yield
-22.0%
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
−$9.27M
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+12.6%
Year over year · more shares
Price change (1Y)
+154.7%
Trailing year
Short interest
—
Latest settlement
Quarterly results
* Q4 derived as the full year minus Q1 to Q3.
Equibles Rating
blended score · not investment adviceOverall
Buy
SellHoldBuy
Technical
Neutral
Momentum
Very Strong
Sentiment
Bearish
Fundamentals
Excellent
Quant / Vol
High
Market backdrop
VIX 18.4 · elevated
Equity put/call 0.55
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
+70%
above
Price vs 50-day avg
+4%
above
RSI (14)
60
neutral
MACD trend
Negative
52-week position
98%
near high
Volume (OBV)
Bearish div.
distributing
Momentum
relative strength
1-month return
+6%
trailing
6-month return
+200%
trailing
YTD return
+157%
this year
Relative strength
+188%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $6 › 200d $3 — 50d above 200d
Institutional flow
Flat
No 13F holder data
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
0.03% of float · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
No 13F holder history
Fundamentals
Revenue growth
+16%
Y/Y
EPS growth
+58%
Y/Y
Free cash flow
$1.4M
Valuation
P/E 1.4
below peers
Balance sheet
$29.9M
net debt
Quant / Vol
risk profile
Volatility
170%
annualized · 1-yr
Max drawdown
−55%
past year
ATR
1.1%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Neutral
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
+70%
Bullish
Price vs 50-day avg
+4%
Bullish
RSI (14)
60
Neutral
MACD trend
Negative
Bearish
52-week position
98%
Bullish
Volume (OBV)
Bearish div.
Bearish
Market signals — smart money & positioning
Bearish · 1 of 6
Trend (MA cross)
No cross
50d $6 › 200d $3 — 50d above 200d
Institutional flow
Flat
No 13F holder data
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
0.03% of float · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
No 13F holder history
Price context
position in its 52-week range
Range low $2
Now $6 · 98%
Range high $6
vs 200-day avg +70%
vs 50-day avg +4%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
KPI extraction has been attempted, but no publishable series is available from the examined filings. This is not evidence that the company reports no KPIs.
Versus peers
Medical Care Facilities — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
GBCS
this stock
Selectis Health, Inc.
|
$17.57M | +157.0% | +15.8% | 1.4 | 0.0% |
|
HCA
HCA Healthcare, Inc.
|
$100.91B | -2.6% | +7.1% | 15.3 | 2.2% |
|
FSNUY
Fresenius SE & Co. KGaA
|
$28.52B | -11.7% | — | — | 0.0% |
|
THC
Tenet Healthcare Corp
|
$21.45B | +34.1% | +0.9% | 10.3 | 2.3% |
|
EHC
Encompass Health Corp
|
$12.01B | +14.7% | +10.5% | 19.8 | 3.5% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionShort & Settlement
Financials
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| GBCS | -0.2% | +5.7% | +200.0% | -0.4% | +157.0% |
| SPY | -0.4% | -0.2% | +12.4% | +0.2% | +12.0% |
| vs SPY | +0.3% | +5.9% | +187.6% | -0.5% | +144.9% |